Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes part II. Caffeic, chlorogenic and rosmarinic acids

Phytotherapy Research

Volumn 18, Issue 5, 2004, Pages 408-413

  Chlopčíková, Šárka ^a   Psotová, Jitka ^a   Miketová, Petra ^a   Soušek, Jaromír ^b   Lichnovský, Václav ^a   Šimánek, Vilím ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b Department of Clinical Biochemistry   (Czech Republic)

Author keywords

Caffeic acid; Cardiomyocytes; Chlorogenic acid; Cytoprotectivity; Doxorubicin; Membranes; Rosmarinic acid

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADJUVANT; ANTHRACYCLINE; CAFFEIC ACID; CHLOROGENIC ACID; DOXORUBICIN; IRON; LACTATE DEHYDROGENASE; PHENOL; RAZOXANE; ROSMARINIC ACID; TROPONIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL ENERGY; CELL PROTECTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG ISOLATION; DRUG RESEARCH; DRUG SCREENING; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HEART PROTECTION; IC 50; LIPID PEROXIDATION; MALE; MEMBRANE STABILIZATION; MICROSCOPY; MICROSOME; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; CAFFEIC ACIDS; CHLOROGENIC ACID; CINNAMATES; DEPSIDES; DOXORUBICIN; HEART DISEASES; INHIBITORY CONCENTRATION 50; LIPID PEROXIDATION; MALE; MICROSOMES; MITOCHONDRIA, HEART; MYOCARDIUM; MYOCYTES, CARDIAC; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; PROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 2942567829     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1461     Document Type: Article

References (40)

1. Aboobaker VS, Balgi AD, Bhattacharya RK. 1994. In vivo effect of dietary factors on the molecular action of aflatoxin B1: role of non-nutrient phenolic compounds on the catalytic activity of liver fractions. In Vivo 8: 1095-1098.
2. Van Acker SABE, Van den Berg DJ, Tromp MNJL, et al. 1996. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 20: 331-342.
3. Ahn CH, Choi WC, Kong JY, Ahn CH, Choi WC, Kong JY. 1997. Chemosensitizing activity of caffeic acid in multidrug-resistant MCF-7/Dox human breast carcinoma cells Anticancer Res 17: 1913-1917.
4. Aziz NH, Farag SE, Mousa LA, Abo-Zaid MA. 1998. Comparative antibacterial and antifungal effects of some phenolic compounds. Microbios 93: 43-54.
5. Blum RH, Carter SK. 1975. Adriamycin, a new anticancer drug with significant clinical activity. Ann Intern Med 80: 249-259.
6. Bradford MM. 1976. Rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
7. Buege JA, Aust SD. 1978. Microsomal lipid peroxidation. Methods Enzymol 52: 302-310.
8. Castelluccio C, Paganga G, Melikian N, et al. 1995. Antioxidant potential of intermediates in phenylpropanoid metabolism in higher plants. FEBS Lett 368: 188-192.
9. Chen JH, Ho CT. 1997. Antioxidant activities of caffeic acid and its related hydroxycinnamic acids compounds. J Agric Food Chem 45: 2374-2378.
10. Conney AH, Lysz T, Ferraro T, et al. 1991. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv Enzy Regul 31: 385-389.
11. Doroshow JH, Davies KJA. 1986. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J Biol Chem 261: 3068-3074.
12. Dorr RT, Bozak KA, Shipp NG, Hendrix M, Alberts DS, Ahmann F. 1988. In vitro rat myocyte cardiotoxicity model for antitumor antibiotics using adenosine triphosphate/protein rations. Cancer Res 48: 5222-5227.
13. Dorr RT. 1996. Cytoprotective agents for anthracyclines. Semin Oncol 23: 23-34.
14. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J, Kohn KW. 1994. Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem Pharmacol 48: 595-608.
15. Gille L, Nohl H. 1997. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med 23: 775-782.
16. Hasinoff BB, Hellmann K, Herman EH, Ferrans VJ. 1998. Chemical, biological and clinical aspects of dextrazoxan and other bisdioxopiperazines. Curr Med Chem 5: 1-28.
17. Hooker CW, Lott WB, Harrich D. 2001. Inhibitor of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription. J Virol 75: 3095-3104.
18. Jeyaseelan R, Poizat C, Wu HY, Kedes L. 1997. Molecular mechanisms of doxorubicin-induced cardiomyopathy. J Biol Chem 272: 5828-5832.
19. Jiang Y, Kusama K, Satoh K, Takayama E, Watanabe S, Sakagami H. 2000. Induction of cytotoxicity by chlorogenic acid in human oral tumor cell lines. Phytomedicine 7: 483-491.
20. Kelm MA, Nair MG, Strasburg GM, DeWitt DL. 2000. Antioxidant and cyclooxygenase inhibitory of phenolic compounds from Ocimum sanctum Linn. Phytomedicine 7: 7-13.
21. Klener P. 1994. Dexrazoxanum. Remedia 4: 88-92.
22. Kono Y, Shibata H, Kodama Y, Sawa Y. 1995. The suppression of the N-nitrosating reaction by chlorogenic acid. Biochem J 312: 947-953.
23. Legha SS, Wang YM, Mackay B, et al. 1982. Clinical and pharmacological investigation of the effects of α-tocopherol on adriamycin cardiotoxicity. Ann N Y Acad Sci 393: 411-418.
24. List AF, Heaton R, Glinsmann-Gibson B, Capizzi RL. 1996. Amifostine protects primitive hematopoetic progenitors against chemotherapy cytotoxicity. Semin Oncol 23: 58-63.
25. Makino T, Ono T, Muso E, Yoshida H, Honda G, Sasayama S. 2000. Inhibitor effects of rosmarinic acid on the proliferation of cultured murine mesangial cells. Nephrol Dial Transplant 15: 1140-1145.
26. Mazumder A, Wang S, Neamati N, et al. 1996. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J Med Chem 39: 2472-2481.
27. Mori H, Kawabata K, Matsunaga K, et al. 2000. Chemopreventive effects of coffee bean and rice constituents on colorectal carcinogenesis. Biofactors 12: 101-105.
28. Nakazawa T, Ohsawa K. 1998. Metabolism of rosmarinic acid in rats. J Nat Prod 61: 993-996.
29. Nardini M, D'Aquino M, Tomassi G, Gentili V, Di Felice M, Scaccini C. 1995. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic Biol Med 19: 541-552.
30. Nardini M, Leonardi F, Scaccini C, Virgili F. 2001. Modulation of ceramide-induced NK-κB binding activity and apoptotic response by caffeic acid in U937 cells: Comparison with other antioxidants. Free Radic Biol Med 30: 722-733.
31. Olson RD, Mushlin PS. 1990. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 4: 3076-3086.
32. Olthof MR, Hollman PC, Katan MB. 2001. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131: 66-71.
33. Packer L. 2001. Flavonoids and other phenolics. Methods Enzymol 335: 302-310.
34. Psotová J, Marková H, Kolař, M, Soušek J, Vičar J, Ulrichová J. 2002. Biological activities of Prunella vulgaris extract. Phytother Res 17: 1082-1087.
35. Radtke J, Linseisen J, Wolfram GZ. 1998. Phenolic acid intake of adults in a Bavarian subgroup of the national food consumption survey. Ernahrungswiss 37: 190-197.
36. Rechner AR, Pannala AS, Rice-Evans CA. 2001a. Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo. Free Radic Res 35: 195-202.
37. Rechner AR, Spencer JP, Kuhnle G, Hahn U, Rice-Evans CA. 2001b. Novel biomarkers of the metabolism of caffeic acid derivatives in vivo. Free Radic Biol Med 30: 1213-1222.
38. Saito K, Oku T, Ata N, Miyashiro H, Hattori M, Saiki I. 1997. A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors Biol Pharm Bull 20: 345-348.
39. Slanina J, Táborská E, Musil P. 1993. Determination of cynarine in the artichoke (Cynara cardunculus L.,) by the HPLC method. Českoslov Farm 42: 275-278.
40. Stavric B. 1997. Chemopreventive agents in foods. In Functionality of Food Phytochemicals, Johns T, Romeo JT (eds). Plenum Press: London, 53-87.